首站-论文投稿智能助手
典型文献
Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase Ⅱ trial
文献摘要:
Objective: Sentinel lymph node biopsy (SLNB) is currently the standard of care in clinically node negative (cN0) breast cancer. The present study aimed to evaluate the negative predictive value (NPV) of 18F-FDG dedicated lymph node positron emission tomography (LymphPET) in cN0 patients.Methods: This was a prospective phase Ⅱ trial divided into 2 stages (NCT04072653). In the first stage, cN0 patients underwent axillary LymphPET followed by SLNB. In the second stage, SLNB was omitted in patients with a negative preoperative axillary assessment after integration of LymphPET. Here, we report the results of the first stage. The primary outcome was the NPV of LymphPET to detect macrometastasis of lymph nodes (LN-macro). Results: A total of 189 patients with invasive breast cancer underwent LymphPET followed by surgery with definitive pathological reports. Forty patients had LN-macro, and 16 patients had only lymph node micrometastasis. Of the 131 patients with a negative LymphPET result, 16 patients had LN-macro, and the NPV was 87.8%. After combined axillary imaging evaluation with ultrasound and LymphPET, 100 patients were found to be both LymphPET and ultrasound negative, 9 patients had LN-macro, and the NPV was 91%. Conclusions: LymphPET can be used to screen patients to potentially avoid SLNB, with an NPV > 90%. The second stage of the SOAPET trial is ongoing to confirm the safety of omission of SLNB according to preoperational axillary evaluation integrating LymphPET.
文献关键词:
作者姓名:
Junjie Li;Jingyi Cheng;Guangyu Liu;Yifeng Hou;Genghong Di;Benglong Yang;Yizhou Jiang;Liang Huang;Feilin Qu;Sheng Chen;Yan Wang;Keda Yu;Zhimin Shao
作者机构:
Department of Breast Surgery,Fudan University Shanghai Cancer Center,and Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,China;Key Laboratory of Breast Cancer in Shanghai,Fudan University Shanghai Cancer Center,Fudan University,Shanghai 200032,China;Department of Nuclear Medicine,Fudan University Shanghai Cancer Center,Shanghai 200032,China
引用格式:
[1]Junjie Li;Jingyi Cheng;Guangyu Liu;Yifeng Hou;Genghong Di;Benglong Yang;Yizhou Jiang;Liang Huang;Feilin Qu;Sheng Chen;Yan Wang;Keda Yu;Zhimin Shao-.Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase Ⅱ trial)[J].癌症生物学与医学(英文版),2022(07):1100-1108
A类:
LymphPET,NCT04072653,macrometastasis,micrometastasis,SOAPET,preoperational
B类:
Feasibility,sentinel,lymph,biopsy,omission,after,integration,18F,FDG,dedicated,early,breast,cancer,prospective,phase,trial,Objective,Sentinel,SLNB,currently,standard,care,clinically,negative,cN0,present,study,aimed,evaluate,predictive,value,NPV,positron,emission,tomography,patients,Methods,This,was,divided,into,stages,In,first,underwent,axillary,followed,by,second,omitted,preoperative,assessment,Here,results,primary,outcome,detect,nodes,Results,total,invasive,surgery,definitive,pathological,reports,Forty,had,only,Of,After,combined,imaging,evaluation,ultrasound,were,found,be,both,Conclusions,used,screen,potentially,avoid,ongoing,confirm,safety,according,integrating
AB值:
0.381573
相似文献
Value of contrast-enhanced ultrasound combined with percutaneous ultrasound-guided fine-needle aspiration in the diagnosis of solid pancreatic lesions
Gui Yang;Dai Menghua;Meng Zhilan;Chang Xiaoyan;Tan Li;Zhang Jing;Chen Xueqi;Zhou Tongtong;Zhang Qing;Xiao Mengsu;Lyu Ke;Jiang Yuxin-Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China;Department of Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China;Department of Pathology, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China
Coupling radiomics analysis of CT image with diversification of tumor ecosystem:A new insight to overall survival in stage Ⅰ-Ⅲ colorectal cancer
Yanqi Huang;Lan He;Zhenhui Li;Xin Chen;Chu Han;Ke Zhao;Yuan Zhang;Jinrong Qu;Yun Mao;Changhong Liang;Zaiyi Liu-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Department of Radiology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;Department of Radiology,the Third Affiliated Hospital of Kunming Medical University,Yunnan Cancer Hospital,Yunnan Cancer Center,Kunming 650118,China;Department of Radiology,Guangzhou First People's Hospital,School of Medicine,South China University of Technology,Guangzhou 510180,China;Department of Radiology,the Affiliated Cancer Hospital of Zhengzhou University&Henan Cancer Hospital,Zhengzhou 450003,China;Department of Radiology,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400042,China
Prognostic and incremental value of computed tomography-based radiomics from tumor and nodal regions in esophageal squamous cell carcinoma
Bangrong Cao;Kun Mi;Wei Dai;Tong Liu;Tianpeng Xie;Qiang Li;Jinyi Lang;Yongtao Han;Lin Peng;Qifeng Wang-Radiation Oncology Key Laboratory of Sichuan Province Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Biobank Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Thoracic Surgery Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Medical Imaging Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Radiation Oncology,Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
Binghe Xu;Huiping Li;Zefei Jiang;Lin Gu;Jinhai Tang;Hui Xie;Yueyin Pan;Yunjiang Liu;Shude Cui;Xiaojia Wang;Li Cai;Yiqiong Zhang;Huadong Zhao;Zhimin Shao-Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China;Department of Breast Cancer,Tianjin Cancer Institute and Hospital,Tianjin 300060,China;Department of Breast Cancer,Jiangsu Provincial Hospital,Nanjing 210029,China;Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology,Hefei 230001,China;Department of Breast Cancer,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Breast Cancer,Henan Cancer Hospital,Zhengzhou 450008,China;Department of Breast Cancer,Zhejiang Cancer Hospital,Hangzhou 310012,China;Department of Breast Cancer,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Clinical Development,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Statistics,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University,Shanghai 200032,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。